ENV-308

A new way to
treat obesity

ENV-308 is a new investigational drug that is being
evaluated for the treatment of obesity.

By signing up, you are consenting to receive news and
updates from Enveda. This is not a qualification for any clinical trial.

First Name(Required)

Last Name(Required)

Email Address(Required)

Phone Number(Required)

Zip COde(Required)

ENV-308 is an investigational compound not approved by the FDA. Safety and
efficacy have not been established.